CDC DESIGNATES GLOBAL TUBERCULOSIS INSTITUTE AT RUTGERS NEW JERSEY MEDICAL SCHOOL AS “NATIONAL CENTER OF EXCELLENCE”
New recognition includes grant award for over $6.7 million

NEWARK, NJ – December 20, 2017 - The Rutgers New Jersey Medical School is pleased to announce that its Global Tuberculosis Institute (GTBI) has been designated by the National Centers of Disease Control and Prevention (CDC) as one of four tuberculosis National Centers of Excellence (COE).

Accompanied by a five-year grant award of over $6,700,000, this distinct designation is the first-ever applied for tuberculosis diagnosis, treatment, control, research, and training and education.

National Centers of Excellence will support regional TB control and prevention efforts by focusing on two major activities: 1) increasing human resource development through education and training activities and 2) increasing the capacity for appropriate medical evaluation and management of persons with TB disease and latent TB infection through medical consultation. Other COEs are located in Gainesville, FL; Oakland, CA; and San Antonio, TX.

“It is truly an honor to be recognized by CDC in our ongoing work to conquer and cure tuberculosis,” said Alfred Lardizabal, MD, GTBI executive director and associate professor of medicine at Rutgers New Jersey Medical School. “The new Center of Excellence designation and award funding will help us achieve our mission to advance tuberculosis care through excellence in research, practice and teaching.”

Support from CDC has enabled GTBI to play a key role in addressing the tuberculosis crisis nationally, at the state level throughout New Jersey, and within the local community in Newark. Consequently, GTBI has contributed significantly to the efforts that have brought TB to present-day historical lows.

In aggregated total, CDC has funded GTBI over $50 million since it was initially established in 1993. Other sources of funding include New Jersey State Department of Health, which has contributed an additional $25.5 million for clinical activities.

As it approaches its 25th anniversary in 2018, GTBI has trained almost 22,000 health professionals, in more than 370 training activities. It has also provided more than 175 lectures to over 12,400 participants.

For more information about the Global Tuberculosis Institute at the Rutgers New Jersey Medical School, please visit the center’s website at: globaltb.njms.rutgers.edu.

For additional information, contact: 
Tiffany J. Cody
Director, Marketing and Communications
Rutgers New Jersey Medical School
Rutgers Biomedical and Health Sciences
tcody@njms.rutgers.edu
(O) 973-972-3501